Live Analyst Rating Changes 1348 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Vikram Gandhi
HSBC
Vikram Gandhi
Wall Street Analyst
★★★★☆
#660
on 13Foresight · ranked by our own returns
78%
Success Rate
+2.4%
Average Return
7 of 9 calls profitable · -10.6% vs benchmark
📈 Across the calls we could measure, roughly 78% of Vikram Gandhi's ratings turned a profit when each position was held for 1 year — averaging +2.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

3 Buy 4 Hold 0 Sell
Vikram's Stock Coverage 20 ratings · 2026-06-18
Company Date Position Consensus Price Target 1-Yr Return
KKR
KKR & Co
Jan 27, 2026 BUY Strong Buy
+7.0% avg upside
32 analysts
$144.00
47.54% Upside
-14.9%
PGR
Progressive
Jan 16, 2026 HOLD Buy
+9.4% avg upside
29 analysts
$224.00
10.31% Upside
+1.3%
CB
Chubb
Jan 16, 2026 BUY Buy
-6.8% avg upside
32 analysts
$354.00
8.98% Upside
+8.8%
TRV
Travelers Companies
Aug 01, 2025 HOLD Hold
-6.1% avg upside
32 analysts
$289.00
4.90% Downside
+20.7%
BX
Blackstone Group
Apr 15, 2025 HOLD Strong Buy
+4.2% avg upside
33 analysts
$132.00
5.68% Upside
+0.8%
TSE:BAM
Brookfield Asset Management Ltd. Class A
Apr 15, 2025 BUY Buy
+20.2% avg upside
18 analysts
$74.72
11.14% Upside
·
AIG
American International Group
Mar 05, 2025 BUY Buy
+12.3% avg upside
32 analysts
$93.00
25.44% Upside
+0.6%
ALL
Allstate
Mar 27, 2024 BUY Buy
-9.2% avg upside
34 analysts
$190.00
13.23% Downside
+25.7%
CH:ZURN
Zurich Insurance Group
Jan 17, 2023 HOLD Sell
+0.7% avg upside
14 analysts
$475.00
17.19% Downside
·
CH:SREN
Swiss Re AG
Dec 14, 2022 HOLD Buy
-1.2% avg upside
12 analysts
$83.00
32.03% Downside
·
GB:0Q99
ageas NV
Dec 14, 2022 HOLD Buy
-11.4% avg upside
7 analysts
$37.50
44.08% Downside
·
DE:ALV
Allianz
Dec 14, 2022 HOLD Buy
-7.4% avg upside
20 analysts
$210.00
47.51% Downside
·
IT:G
Assicurazioni Generali S.p.A.
Dec 14, 2022 HOLD Buy
-15.4% avg upside
15 analysts
$16.45
61.23% Downside
·
FR:CS
AXA SA
Dec 14, 2022 BUY Strong Buy
+4.5% avg upside
17 analysts
$31.00
26.82% Downside
·
DE:HNR1
Hannover Rueck
Dec 14, 2022 BUY Buy
+13.8% avg upside
13 analysts
$200.00
13.91% Downside
·
DE:MUV2
Munich Reinsurance
Dec 14, 2022 BUY Buy
+6.6% avg upside
13 analysts
$320.00
31.21% Downside
·
FR:SCR
SCOR
Dec 14, 2022 HOLD Buy
+0.5% avg upside
9 analysts
$20.00
35.78% Downside
·
DE:TLX
Talanx AG
Dec 14, 2022 BUY Strong Buy
-5.2% avg upside
6 analysts
$49.00
53.46% Downside
·
MURGY
Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft Unsponsored ADR
Mar 05, 2020 BUY Buy
5 analysts
+19.1%
SSREY
Swiss Re
Mar 18, 2019 HOLD Strong Buy
+263.2% avg upside
3 analysts
-40.2%
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Vikram Gandhi — Frequently Asked Questions
How accurate are Vikram Gandhi's stock ratings?
Based on the calls 13Foresight could measure, about 78% of Vikram's ratings were profitable over a one-year hold, with an average return of +2.4% per rating, or -10.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Vikram ranked on 13Foresight?
Vikram Gandhi is currently ranked #660 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Vikram cover?
Vikram most recently has ratings on KKR, PGR, CB, TRV, BX, TSE:BAM, AIG, ALL, CH:ZURN, CH:SREN, GB:0Q99, DE:ALV and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.